Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Dry powder inhalations in the treatment of pulmonary tuberculosis

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: MISRA, Amit (CSIR-Central Drug Research Institute, Pharmaceutics Division, Lucknow, India)
  • Abstract:

    Background: Although tuberculosis (TB) is primarily a lung disease, standard chemotherapy requires oral administration of a long duration regimen. Significant adverse effects are often seen.
    Aim: We wanted a dry powder inhalation (DPI) that could target drugs to lung macrophages, and also stimulate these cells to overcome the state of alternative..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses